Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders

CBM has the potential to help many people with metabolic disorders, diabetes and eating problems.
April 22, 2020

This post is also available in: Español

Today on the radar of new cannabinoids we have cannabimovone  (CBM),  a cannabinoid that according to research is found in various cannabis genetics and that could be a revolutionary compound to analyze the way in which the human body behaves against externals or internal agents.

A new study published in MDPI earlier this year shows that CBM used in clinical trials has the potential to help many people with metabolic disorders, diabetes and eating problems.

CBM contains a known active agent derived from a genetic known as "Carmagnola"” which according to some experts could be the future of medical research with CBD.

An important discovery

According to the study, from a technical point of view, this CBM cannabinoid behaves similarly to CBD or THC. However, a new important focus of study has been found. According to this new research, it was shown that this cannabinoid adheres to important body receptors such as PPARα and PPAR,γ, vital in neuronal  functioning.

For those who do not family with these concepts, it has been shown that PPARα and PPARγ are responsible forthe ordering of our genetic material, as well as the creation of new key cells within our organisms.

These include the kidneys, colon, heart, and liver. These receptors are responsible for hormonal, metabolic regulation and are directly related to the carcinogenic prevention of certain cancers according to the scientific information available.

Researchers demonstrated by using the models in the lab that CBM has the potential to easily adhere to these receptors and partially activate them. Therefore, if the research continues it could be said that this cannabinoid would serve to treat diabetes or insulin resistance.

Read the full investigation at the link: https://www.ncbi.nlm.nih.gov/pubmed/32138197

This post is also available in: Español

Escrito por: Daniel Gomez
Publicado en la revista 
SíGUENOS EN INSTAGRAM COMO @MCNGLOBAL

Un estudio realizado en Flint Animal Cancer Center de la Universidad de Colorado en Aurora, Estados Unidos, demostró que el cannabidiol (CBD), componente no psicoactivo de cannabis, redujo la frecuencia en las convulsiones de 12 perros a quienes se les administró el tratamiento natural.

El ensayo clínico controlado contó con 26 perros de los cuales 12 recibieron CBD y 14 un placebo. De esta manera se les administró CBD a dosis de 2,5 mg/kg de peso en una solución oleosa dos veces al día durante 12 semanas.

“Los caninos en el grupo de CBD tuvieron una significante reducción en la frecuencia de las convulsiones comparado con el grupo de placebo. Sin embargo, la porción de los perros que tuvieron una respuesta al tratamiento fue similar en ambos grupos”, señala el estudio.
-
Link en Bio.
...

¿Te gustan los concentrados? 🍯 #MCN710 #Extracts #MCN ...

Delta 8 THC y sus derivados solo podrán ser comprados en tiendas de cannabis con licencias. #THC #Delta8THC #USA
-
El Departamento de Protección al Consumidor (#DCP) de los Estados Unidos, anunció este 25 de junio, que las empresas ya no pueden ofrecer ni vender productos derivados del cáñamo de donde se extraiga THC, incluidos los nuevos delta-7, delta-8, delta-9 y delta-10.

Este tipo de componentes se elaboran a partir del cannabidiol (#CBD) a través de un proceso novedoso de extracción y durante los últimos meses ganó gran popularidad entre los productos de cáñamo ya que se considera como un nuevo subproducto con efectos psicoactivo.

No obstante, al ser un componente activo similar al THC, el DCP y la Administración de Alimentos y Medicamentos (#FDA) se puso tras su huella. El 22 de junio del año en curso, los legisladores aprobaron la “Ley Sobre la Preservación Responsable y Equitativa del Cannabis de Uso Adulto”.

Dicha ley procuró incluir los productos a base de cáñamo y sus concentraciones al 0.3% sobre una base de peso seco. Se agregó también el delta-7, 8, 9 y 10. Ahora este tipo de productos se venderán en tiendas minorista con licencias también llamados dispensarios de cannabis.
...

¿Para qué sirve el #CBD? ¿Puedo consumir CBD si no tengo ninguna enfermedad? Las respuestas en este artículo. Link en bio. ...

Lo más reciente en MCN

También te puede interesar

September 23, 2021
First hemp and CBD boutique store opens in Costa Rica

Hemp concept stores are booming in the United States, Europe and arrives for the first time in Costa Rica

Ver Artículo
August 18, 2021
Argentina: Ministry of Health delivers first batch of medical cannabis for children with refractory epilepsies

Treatment with medicinal cannabis will be intended for 14 patients of Garrahan hospital

Ver Artículo
August 11, 2021
Hemp could create batteries three times stronger than lithium batteries

Researchers believe cars and power tools can take advantage of hemp batteries

Ver Artículo
July 29, 2021
Survey: Patients say CBD helps them reduce pain

Most participants – 59% – said these products helped them with pain

Ver Artículo
Copyright Zegreenlab S.A. Todos los derechos reservados © 2020. Hecho en Costa Rica.
Diseño & Desarrollo por Dbugger Studio
Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disordersCannabimovone (CBM) beneficial cannabinoid for diabetes and eating disordersCannabimovone (CBM) beneficial cannabinoid for diabetes and eating disordersCannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders